Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary Review
about
Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspectiveEvaluation of efficacy and effectiveness of live attenuated zoster vaccineCost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgiaLooking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific.Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox.The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster.Cost-effectiveness of vaccination against herpes zoster.Active learning to understand infectious disease models and improve policy making.Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries.Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany.Cytomegalovirus seropositivity is associated with herpes zoster.Varicella-zoster virus susceptibility and primary healthcare consultations in Norway.Estimating Age-Specific Immunity and Force of Infection of Varicella Zoster Virus in Norway Using Mixture Models.Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.Varicella paediatric hospitalisations in Belgium: a 1-year national surveyCurrent and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccinationEfficacy of varicella (VZV) vaccination: an update for the clinician.Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians.The Epidemiology of Herpes Zoster After Varicella Immunization Under Different Biological Hypotheses: Perspectives From Mathematical Modeling.Varicella vaccination - the global experience.Periodicity of varicella-zoster virus in the presence of immune boosting and clinical reinfection with varicella.Prevention of Herpes Zoster and its complications: From clinical evidence to real life experience.Integrating between-host transmission and within-host immunity to analyze the impact of varicella vaccination on zoster.Risk factors for herpes zoster in a large cohort of unvaccinated older adults: a prospective cohort study.Fifteen years of routine childhood varicella vaccination in the United States-strong decrease in the burden of varicella disease and no negative effects on the population level thus far.Review for Disease of the Year: Varicella Zoster Virus-Induced Anterior Uveitis.Should the UK introduce a universal childhood varicella vaccination programme?Post-herpetic neuralgia - a review of current management and future directions.Inequalities in zoster disease burden: a population-based cohort study to identify social determinants using linked data from the UK Clinical Practice Research Datalink.Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study.Varicella and herpes zoster vaccine development: lessons learned.Perspectives on optimal control of varicella and herpes zoster by mass routine varicella vaccination.Trends in herpes zoster epidemiology in Germany based on primary care sentinel surveillance data, 2005-2016.Evaluation of the effect of chickenpox vaccination on shingles epidemiology using agent-based modeling.
P2860
Q26781940-46706362-23A4-4489-8DD9-28CCDE75527DQ26866473-BCF881FE-A2DB-405A-9360-5574E62DEC3CQ28468596-6B57A9CE-66D1-42DB-B110-2C0C2DBF233EQ30235260-C5545A9F-A39D-4979-B6DF-7C6857076B18Q33683179-10E9887E-5F83-4CD5-B4B5-5D04D2042DAEQ33703581-01C83481-DE48-4328-AFD7-6B69415F0C45Q34291150-F0B1016D-06D8-4540-8E6E-D562584491E8Q35151816-5619F0F8-031B-4A9F-890A-34DCEE135DECQ35652212-8B2620F9-0226-4FEF-B85B-06D2888C0FE0Q35886434-92A9EBFF-5854-464A-A740-1DD48282F702Q35887759-ED56E2A1-6A5F-488D-9745-603AEBADD30FQ36041839-7CA9DD90-3737-4700-BA93-5BAE21DED12EQ36149754-2D9F3ED3-3063-4DAA-925D-B8278F83E631Q36252698-DA8C459D-E182-43E1-A956-DD760FEC3E12Q36475701-134794E3-6C20-4577-8DA2-43367705BB3CQ37135445-08738A70-C8B5-435F-B8B3-2EEFA97FD5F3Q37158220-0C71B232-F039-4CCE-B086-3B6F6F035ED0Q37643309-21F4FA3D-B994-4498-A801-9D30574306D4Q38781301-698F6D89-0886-4CEF-906E-159DE9943C42Q39394364-753448D8-A5AF-4FCA-90ED-0C59326092B0Q39689778-83986355-87BC-4C71-90B5-7F6C1EFEBD32Q40437635-128F6572-6237-420C-998C-09AE71504016Q40640266-4C59BF3B-5532-4654-8EBF-C41C7F626E72Q41577013-3A2A5C4B-9422-4B90-8B2B-2225BB408BDDQ41880259-86E3EFE5-9352-461C-9D06-9F29B9FC019AQ41918328-A9A628F5-AD32-4445-8844-CFE08A810A6EQ44749354-D0B7AEDE-821A-447E-AFFB-2ACEDB3C4F04Q47242634-5BB10FC3-4B13-47E1-ADFE-966D35ECA673Q47547508-84916673-0427-4DB4-9230-17CB820F4291Q47556386-4A8911F4-50A1-4E85-A641-15FFB6981922Q47607699-983E8637-BC08-48CC-8DA7-2E7D69303376Q51439781-FA90F71F-59E9-4B0E-813A-72E0C52777E6Q52808704-20657770-8AFA-4182-92A0-E3B6EB73128CQ55338707-F60C4CED-8C28-4772-A97A-90E44BDE8028
P2860
Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary Review
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Herpes Zoster Risk Reduction t ...... matic Multidisciplinary Review
@ast
Herpes Zoster Risk Reduction t ...... matic Multidisciplinary Review
@en
Herpes Zoster Risk Reduction t ...... matic Multidisciplinary Review
@nl
type
label
Herpes Zoster Risk Reduction t ...... matic Multidisciplinary Review
@ast
Herpes Zoster Risk Reduction t ...... matic Multidisciplinary Review
@en
Herpes Zoster Risk Reduction t ...... matic Multidisciplinary Review
@nl
prefLabel
Herpes Zoster Risk Reduction t ...... matic Multidisciplinary Review
@ast
Herpes Zoster Risk Reduction t ...... matic Multidisciplinary Review
@en
Herpes Zoster Risk Reduction t ...... matic Multidisciplinary Review
@nl
P2860
P50
P921
P1433
P1476
Herpes Zoster Risk Reduction t ...... matic Multidisciplinary Review
@en
P2860
P304
P356
10.1371/JOURNAL.PONE.0066485
P407
P5008
P577
2013-06-21T00:00:00Z